An $80,000 grant for The Wistar Institute’s HIV-1 Patient Partnership for Basic Research program from the Robert I. Jacobs Fund of Philadelphia Foundation not only advances ongoing basic research i…
On Friday, February 24, 2023, more than 175 postdoctoral, graduate, and undergraduate students from around Philadelphia came together for the very first Wistar Institute Trainee Research Symposium….
Dr. Luis J. Montaner and lab find common, persistent symptoms for long-haulers by reviewing a multitude of research studies. An international team of researchers led by The Wistar Institute’s lead …
On Friday, February 24, 2023, Wistar convened more than 175 postdoctoral, graduate, and undergraduate students from around Philadelphia for the very first Wistar Trainee Research Symposium at The W…
Some cancers are linked to viral infections. Studying viruses found in tumor cells can reveal important information in the development of more effective cancer treatments. Wistar researchers develo…
What clues can a cell’s death reveal for immunotherapies for treating cancer and other diseases? Wistar scientists Dr. Yulia Nefedova, associate professor in the Immunology, Microenvironment & …
The annual award supports early career investigators and their work advancing in the immunology, vaccine, and immunotherapy space. Noam Auslander, Ph.D., Assistant Professor in the Molecular &…
Heather A. Steinman, Ph.D., M.B.A., joined The Wistar Institute as vice president for business development and executive director of technology transfer in October 2014. Dr. Steinman was hired…
Khumoekae Richard, Ph.D., is a postdoctoral fellow in the HIV lab of Dr. Luis Montaner. Dr. Richard’s early and deep interest in plants and their derivatives as medicines has taken him on a scienti…
Zoomers gathered virtually for the launch of Wistar’s new Diversity in Science seminar series. A leading biomedical research institution of global reputation, Wistar is committed to advancing equit…
